SE9403526D0 - New Peptides - Google Patents

New Peptides

Info

Publication number
SE9403526D0
SE9403526D0 SE9403526A SE9403526A SE9403526D0 SE 9403526 D0 SE9403526 D0 SE 9403526D0 SE 9403526 A SE9403526 A SE 9403526A SE 9403526 A SE9403526 A SE 9403526A SE 9403526 D0 SE9403526 D0 SE 9403526D0
Authority
SE
Sweden
Prior art keywords
new peptides
peptides
homodimers
modulate
administered
Prior art date
Application number
SE9403526A
Other languages
English (en)
Inventor
Haakan Bergstrand
Kostas Karabelas
Magnus Lindvall
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9403526A priority Critical patent/SE9403526D0/sv
Publication of SE9403526D0 publication Critical patent/SE9403526D0/sv
Priority to ZA958140A priority patent/ZA958140B/xx
Priority to IL11550995A priority patent/IL115509A0/xx
Priority to CA002201479A priority patent/CA2201479A1/en
Priority to PL95319631A priority patent/PL319631A1/xx
Priority to CZ971119A priority patent/CZ111997A3/cs
Priority to AU37133/95A priority patent/AU705364B2/en
Priority to BR9509345A priority patent/BR9509345A/pt
Priority to HU9702044A priority patent/HUT77118A/hu
Priority to EE9700087A priority patent/EE9700087A/xx
Priority to SK467-97A priority patent/SK46797A3/sk
Priority to PCT/SE1995/001151 priority patent/WO1996011943A1/en
Priority to JP8513146A priority patent/JPH10507448A/ja
Priority to MX9702666A priority patent/MX9702666A/es
Priority to US08/836,480 priority patent/US6103697A/en
Priority to EP95934921A priority patent/EP0783519A1/en
Priority to TR95/01255A priority patent/TR199501255A2/xx
Priority to IS4459A priority patent/IS4459A/is
Priority to NO971625A priority patent/NO971625L/no
Priority to FI971499A priority patent/FI971499A/sv
Priority to US09/562,897 priority patent/US6228374B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SE9403526A 1994-10-14 1994-10-14 New Peptides SE9403526D0 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE9403526A SE9403526D0 (sv) 1994-10-14 1994-10-14 New Peptides
ZA958140A ZA958140B (en) 1994-10-14 1995-09-27 New peptides with immunomodulatory effects
IL11550995A IL115509A0 (en) 1994-10-14 1995-10-03 New peptides with immunomodulatory effects
EP95934921A EP0783519A1 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects
HU9702044A HUT77118A (hu) 1994-10-14 1995-10-06 Immunmodulátor hatásokkal rendelkező új peptidek
JP8513146A JPH10507448A (ja) 1994-10-14 1995-10-06 免疫調節作用を有する新規ペプチド
CZ971119A CZ111997A3 (en) 1994-10-14 1995-10-06 Peptides exhibiting immunomodulating activity, process of their preparation, pharmaceutical compositions containing thereof and their use
AU37133/95A AU705364B2 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects
BR9509345A BR9509345A (pt) 1994-10-14 1995-10-06 Peptídeo preparação farmacéutica e processos para imunomodulação para preparação de um peptídeo
CA002201479A CA2201479A1 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects
EE9700087A EE9700087A (et) 1994-10-14 1995-10-06 Uued immunomodulatoorse toimega peptiidid
SK467-97A SK46797A3 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects, preparation method thereof, pharmaceutical compositions containing them and their use
PCT/SE1995/001151 WO1996011943A1 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects
PL95319631A PL319631A1 (en) 1994-10-14 1995-10-06 Novel peptiodes having immunomodulating properties
MX9702666A MX9702666A (es) 1994-10-14 1995-10-06 Nuevos peptidos con efectos inmunoreguladores.
US08/836,480 US6103697A (en) 1994-10-14 1995-10-06 Peptides with immunomodulatory effects
TR95/01255A TR199501255A2 (tr) 1994-10-14 1995-10-12 Immunomodülatör tesirli yeni peptidler.
IS4459A IS4459A (is) 1994-10-14 1997-04-08 Ný peptíð er hafa ónæmisbreytandi áhrif
NO971625A NO971625L (no) 1994-10-14 1997-04-09 Nye peptider med immunomodulatoriske effekter
FI971499A FI971499A (sv) 1994-10-14 1997-04-10 Nya peptider med immunomodulatoriska effekter
US09/562,897 US6228374B1 (en) 1994-10-14 2000-05-01 Peptides with immunomodulatory effects

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9403526A SE9403526D0 (sv) 1994-10-14 1994-10-14 New Peptides

Publications (1)

Publication Number Publication Date
SE9403526D0 true SE9403526D0 (sv) 1994-10-14

Family

ID=20395628

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9403526A SE9403526D0 (sv) 1994-10-14 1994-10-14 New Peptides

Country Status (20)

Country Link
US (2) US6103697A (sv)
EP (1) EP0783519A1 (sv)
JP (1) JPH10507448A (sv)
AU (1) AU705364B2 (sv)
BR (1) BR9509345A (sv)
CA (1) CA2201479A1 (sv)
CZ (1) CZ111997A3 (sv)
EE (1) EE9700087A (sv)
FI (1) FI971499A (sv)
HU (1) HUT77118A (sv)
IL (1) IL115509A0 (sv)
IS (1) IS4459A (sv)
MX (1) MX9702666A (sv)
NO (1) NO971625L (sv)
PL (1) PL319631A1 (sv)
SE (1) SE9403526D0 (sv)
SK (1) SK46797A3 (sv)
TR (1) TR199501255A2 (sv)
WO (1) WO1996011943A1 (sv)
ZA (1) ZA958140B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
CA2250707A1 (en) * 1996-04-12 1997-10-23 Astra Aktiebolag Cysteine-containing or methionine-containing peptides with immunomodulatory effects
AU3453897A (en) * 1996-07-08 1998-02-02 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
SE9603467D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603466D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603461D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603462D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
AU9655698A (en) * 1997-10-10 1999-05-03 Astra Aktiebolag Synthetic genes with immunomodulatory effects
EP1083872A1 (en) * 1998-06-03 2001-03-21 GPI NIL Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8080560B2 (en) 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
ES2388684T3 (es) 2005-04-25 2012-10-17 Cadila Pharmaceuticals Limited Adyuvantes de vacunas
KR101363455B1 (ko) * 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
WO1988005783A1 (en) 1987-01-28 1988-08-11 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
FR2622700B1 (fr) 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
EP0341603A3 (en) * 1988-05-09 1990-07-04 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
JP2596466B2 (ja) 1990-03-03 1997-04-02 アサヒビール株式会社 ダニの主要アレルゲンの還伝情報を有するｄｎａおよび該アレルゲンの製造方法
JP3592709B2 (ja) 1990-09-11 2004-11-24 インスティテュート・フォー・チャイルド・ヘルス・リサーチ ダーマトファゴイデス（家塵ダニ）のアレルゲンのクローニングおよびシークエンシング
WO1993000108A1 (en) * 1991-06-28 1993-01-07 Corvas International, Inc. Novel inhibitors of platelet aggregation
JP2657861B2 (ja) 1991-09-17 1997-09-30 アサヒビール株式会社 ダニ主要アレルゲンの製造方法
ATE444360T1 (de) 1991-10-16 2009-10-15 Merck Patent Gmbh T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
JP3149033B2 (ja) 1991-10-30 2001-03-26 アサヒビール株式会社 ダニ主要アレルゲンＤｅｒ ｆ ＩＩ中のペプチド
DE69435292D1 (de) 1993-03-05 2010-06-17 Epimmune Inc Verfahren zur herstellung von immunogenen hla-a2.1-bindenden peptiden
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのｂ細胞エピトープ
US6159937A (en) 1994-07-05 2000-12-12 Steeno Research Group A/S Immunomodulators
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
EP0783519A1 (en) 1997-07-16
CA2201479A1 (en) 1996-04-25
HUT77118A (hu) 1998-03-02
WO1996011943A1 (en) 1996-04-25
BR9509345A (pt) 1997-11-25
SK46797A3 (en) 1997-09-10
MX9702666A (es) 1997-06-28
IL115509A0 (en) 1996-05-14
FI971499A (sv) 1997-06-10
ZA958140B (en) 1997-06-27
FI971499A0 (sv) 1997-04-10
EE9700087A (et) 1997-10-15
TR199501255A2 (tr) 1996-06-21
CZ111997A3 (en) 1997-12-17
IS4459A (is) 1997-04-08
US6103697A (en) 2000-08-15
JPH10507448A (ja) 1998-07-21
NO971625D0 (no) 1997-04-09
AU3713395A (en) 1996-05-06
US6228374B1 (en) 2001-05-08
PL319631A1 (en) 1997-08-18
AU705364B2 (en) 1999-05-20
NO971625L (no) 1997-05-30

Similar Documents

Publication Publication Date Title
SE9403526D0 (sv) New Peptides
MX9606492A (es) Secuencias peptidicas, guias, sinteticas.
EA199800946A1 (ru) Концентрированный препарат антител
ES2051806T3 (es) Preparados de proteina humana estables.
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
DK68991D0 (da) Manifold
AU558812B2 (en) Dentifrice containing partially hydrolyzed protein fraction rich in positively charged amino acids
DE69434384D1 (de) Metalkomplexbildner
AU560264B2 (en) Partially hydrolyzed protein fraction rich in positively charged amino acids in detergents reduce irritation
ES2157523T3 (es) Solucion de dialisis peritoneal.
DK0707473T3 (da) Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler
ES2142840T3 (es) Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen.
ES8302433A1 (es) "procedimiento de preparar agentes edulcorantes".
DE3268716D1 (en) Peptides and process for their preparation
FI942392A (sv) Peptider och antikroppar för vårdande av ledinflammation
DE69613086D1 (de) Antigenen Peptide mit Glycinsubstitution
ATE315646T1 (de) Leukocyten-aktivierender faktor
DK1612555T3 (da) Kryptiske peptider til anvendelse til at inducere immunologisk tolerance
DK0540560T3 (da) Ancrod-lignende proteiner, fremstilling og anvendelse deraf
AU525042B2 (en) Ovulation enhancing peptides
DE68914057T2 (de) Peptide.
SI0888286T1 (en) Novel substituted cyclic amino acids as pharmaceutical agents